Search research articles
Contact Us
Filters
Showing results (131-140 of 157) with videos related to
Page
of 16
Sort By:
Hepatology (Baltimore, Md.)
|
October 27, 1997
Transient immunosuppression with FK506 permits long-term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the rat
Y Ilan, V K Jona, K Sengupta, et al.
Blood
|
May 29, 2000
Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine model
Y Ilan, I Gotsman, M Pines, et al.
The Journal of Pathology
|
December 18, 2001
Immunomodulation of experimental colitis: the role of NK1.1 liver lymphocytes and surrogate antigens--bystander effect
A Shlomai, S Trop, I Gotsman, et al.
Transplantation
|
July 15, 1997
Massive repopulation of rat liver by transplantation of hepatocytes into specific lobes of the liver and ligation of portal vein branches to other lobes
Y Ilan, N Roy-Chowdhury, R Prakash, et al.
The Journal of Clinical Investigation
|
March 1, 1997
Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors
Y Ilan, R Prakash, A Davidson, et al.
Vaccine
|
November 1, 1994
Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines
D Shouval, Y Ilan, R Adler, et al.
Transplantation Proceedings
|
June 18, 1999
Solid tumors after liver transplantation
R Safadi, Y Ilan, A Eid, et al.
Transplantation Proceedings
|
June 18, 1999
Primary sclerosing cholangitis and liver transplantation
R Safadi, Y Ilan, E Galun, et al.
Journal of Viral Hepatitis
|
November 22, 2014
Oral anti-CD3 immunotherapy for HCV-nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase-2a placebo-controlled trial
W Halota, P Ferenci, D Kozielewicz, et al.
BMC Gastroenterology
|
November 29, 2017
Attenuating the rate of total body fat accumulation and alleviating liver damage by oral administration of vitamin D-enriched edible mushrooms in a diet-induced obesity murine model is mediated by an anti-inflammatory paradigm shift
A Drori, D Rotnemer-Golinkin, S Avni, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 157) with videos related to
Sort By:
Page
of 16
Hepatology (Baltimore, Md.)
|
October 27, 1997
Transient immunosuppression with FK506 permits long-term expression of therapeutic genes introduced into the liver using recombinant adenoviruses in the rat
Y Ilan, V K Jona, K Sengupta, et al.
Blood
|
May 29, 2000
Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine model
Y Ilan, I Gotsman, M Pines, et al.
The Journal of Pathology
|
December 18, 2001
Immunomodulation of experimental colitis: the role of NK1.1 liver lymphocytes and surrogate antigens--bystander effect
A Shlomai, S Trop, I Gotsman, et al.
Transplantation
|
July 15, 1997
Massive repopulation of rat liver by transplantation of hepatocytes into specific lobes of the liver and ligation of portal vein branches to other lobes
Y Ilan, N Roy-Chowdhury, R Prakash, et al.
The Journal of Clinical Investigation
|
March 1, 1997
Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors
Y Ilan, R Prakash, A Davidson, et al.
Vaccine
|
November 1, 1994
Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines
D Shouval, Y Ilan, R Adler, et al.
Transplantation Proceedings
|
June 18, 1999
Solid tumors after liver transplantation
R Safadi, Y Ilan, A Eid, et al.
Transplantation Proceedings
|
June 18, 1999
Primary sclerosing cholangitis and liver transplantation
R Safadi, Y Ilan, E Galun, et al.
Journal of Viral Hepatitis
|
November 22, 2014
Oral anti-CD3 immunotherapy for HCV-nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase-2a placebo-controlled trial
W Halota, P Ferenci, D Kozielewicz, et al.
BMC Gastroenterology
|
November 29, 2017
Attenuating the rate of total body fat accumulation and alleviating liver damage by oral administration of vitamin D-enriched edible mushrooms in a diet-induced obesity murine model is mediated by an anti-inflammatory paradigm shift
A Drori, D Rotnemer-Golinkin, S Avni, et al.
Page
of 16